Salveen Richter
Stock Analyst at Goldman Sachs
(3.52)
# 901
Out of 5,240 analysts
216
Total ratings
43.33%
Success rate
7.12%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANNX Annexon | Initiates: Neutral | $7 | $5.38 | +30.11% | 1 | May 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Reinstates: Neutral | $69 | $53.05 | +30.07% | 2 | May 11, 2026 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $41 → $59 | $43.13 | +36.80% | 2 | May 8, 2026 | |
| MRNA Moderna | Maintains: Neutral | $43 → $49 | $50.22 | -2.43% | 12 | May 4, 2026 | |
| RLAY Relay Therapeutics | Maintains: Buy | $13 → $22 | $12.82 | +71.61% | 4 | Apr 28, 2026 | |
| NTLA Intellia Therapeutics | Maintains: Sell | $8 → $9 | $13.30 | -32.33% | 9 | Apr 28, 2026 | |
| QURE uniQure | Maintains: Neutral | $9 → $10 | $28.25 | -64.60% | 11 | Apr 20, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $28 → $32 | $28.87 | +10.84% | 11 | Apr 1, 2026 | |
| DNLI Denali Therapeutics | Maintains: Buy | $35 → $40 | $19.59 | +104.19% | 6 | Mar 26, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgrades: Neutral | $61 → $25 | $26.23 | -4.69% | 4 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $16.16 | +60.94% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $16 | $24.58 | -34.91% | 4 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $45 → $65 | $77.06 | -15.65% | 5 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $26 → $18 | - | - | 9 | Sep 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $22.15 | +17.38% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $504 → $566 | $293.79 | +92.65% | 6 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $38 | $10.00 | +280.00% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $19 | $19.05 | -0.26% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $22.20 | -23.42% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $50.75 | -7.39% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $17.97 | +128.16% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $13.17 | -24.07% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $718.11 | +11.96% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $196.28 | +0.37% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $133.26 | -27.96% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $141.42 | -49.09% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $98.37 | -28.84% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $336.81 | +3.92% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $455.00 | +22.86% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $39.59 | -87.37% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.20 | +1,309.09% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $233.87 | -3.79% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $3.20 | +588.58% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.42 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $8.21 | +265.41% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $3.12 | +188.46% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $6.40 | -53.13% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.25 | +84.62% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $85.54 | -49.73% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $4.05 | -50.65% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $10.13 | +886.99% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $5.25 | +11,328.57% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $112.18 | -55.43% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $79.80 | -43.61% | 1 | Mar 17, 2020 |
Annexon
May 12, 2026
Initiates: Neutral
Price Target: $7
Current: $5.38
Upside: +30.11%
BioMarin Pharmaceutical
May 11, 2026
Reinstates: Neutral
Price Target: $69
Current: $53.05
Upside: +30.07%
Enliven Therapeutics
May 8, 2026
Maintains: Buy
Price Target: $41 → $59
Current: $43.13
Upside: +36.80%
Moderna
May 4, 2026
Maintains: Neutral
Price Target: $43 → $49
Current: $50.22
Upside: -2.43%
Relay Therapeutics
Apr 28, 2026
Maintains: Buy
Price Target: $13 → $22
Current: $12.82
Upside: +71.61%
Intellia Therapeutics
Apr 28, 2026
Maintains: Sell
Price Target: $8 → $9
Current: $13.30
Upside: -32.33%
uniQure
Apr 20, 2026
Maintains: Neutral
Price Target: $9 → $10
Current: $28.25
Upside: -64.60%
Agios Pharmaceuticals
Apr 1, 2026
Maintains: Neutral
Price Target: $28 → $32
Current: $28.87
Upside: +10.84%
Denali Therapeutics
Mar 26, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $19.59
Upside: +104.19%
Ultragenyx Pharmaceutical
Mar 24, 2026
Downgrades: Neutral
Price Target: $61 → $25
Current: $26.23
Upside: -4.69%
Mar 24, 2026
Initiates: Buy
Price Target: $26
Current: $16.16
Upside: +60.94%
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $24.58
Upside: -34.91%
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $77.06
Upside: -15.65%
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: -
Upside: -
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $22.15
Upside: +17.38%
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $293.79
Upside: +92.65%
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $10.00
Upside: +280.00%
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $19.05
Upside: -0.26%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $22.20
Upside: -23.42%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $50.75
Upside: -7.39%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $17.97
Upside: +128.16%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $13.17
Upside: -24.07%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $718.11
Upside: +11.96%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $196.28
Upside: +0.37%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $133.26
Upside: -27.96%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $141.42
Upside: -49.09%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $98.37
Upside: -28.84%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $336.81
Upside: +3.92%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $455.00
Upside: +22.86%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $39.59
Upside: -87.37%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.20
Upside: +1,309.09%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $233.87
Upside: -3.79%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $3.20
Upside: +588.58%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $19.42
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $8.21
Upside: +265.41%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $3.12
Upside: +188.46%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $6.40
Upside: -53.13%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.25
Upside: +84.62%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $85.54
Upside: -49.73%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $4.05
Upside: -50.65%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $10.13
Upside: +886.99%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $5.25
Upside: +11,328.57%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $112.18
Upside: -55.43%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $79.80
Upside: -43.61%